June 29, 2026 · Form 4 insider transaction
Patel Sushil sold 900 shares of Revolution Medicines, Inc. at $184.59 per share, a transaction worth $166.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026.; The transaction was executed in multiple trades in prices ranging from $184.08 to $184.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 1,191 restricted stock units.